Literature DB >> 21601305

Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.

Rui Wang1, Jie Zhang, Sufeng Chen, Meng Lu, Xiaoyang Luo, Shihua Yao, Shilei Liu, Ying Qin, Haiquan Chen.   

Abstract

OBJECTIVE: It remains largely unknown whether tumor-associated macrophages (TAMs) are involved in invasion and metastasis of human lung cancer. The aim of our study was to obtain an accurate overview of the broad range of changes occurring in monocytes that develop into TAMs, and the roles of TAMs during the progression of non-small cell lung cancer.
METHODS: TAM was isolated from 98 primary lung cancer tissues by short term cultivation in serum-free medium. The mRNA expression levels of 9 genes, including EGF, Cathepsin K, Cathepsin S, COX-2, MMP-9, PDGF, uPA, VEGFA, HGF, were evaluated by real-time PCR in 98 NSCLC. The relationships between those gene expression levels and clinicopathological features were investigated. The effects of conditioned medium from TAMs on the invasive properties of different lung cancer cell lines were measured using Transwell chambers.
RESULTS: We successfully achieved up to 95% purity of TAM, derived from 98 primary lung cancer tissues. TAM expressed high levels of Cathepsin K, COX-2, MMP-9, PDGF-B, uPA, VEGFA, and HGF. Phenotypic expression on TAMs, like MMP9, was shown to be correlated with disease progression by analyzing lung cancer tissues. Conditioned medium from TAM significantly increased cell migration and invasion in SPC-A1 cells, H460 cells and A549 cells. Anti-uPA and anti-MMP-9, but not anti-VEGF monoclonal antibodies, can inhibit TAM-induced invasion. The increase of invasiveness in the lung cancer cell lines was also correlated with their gelatinase activity, through MMP9.
CONCLUSIONS: Short-term culture in serum free medium is an effective way to isolate TAM in NSCLC. The results of this study also demonstrated that those up-regulated genes in TAMs contributed to suitable microenvironments for lung cancer invasion and metastasis. These findings may be useful in developing novel therapeutic strategies to prevent lung cancer progression.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601305     DOI: 10.1016/j.lungcan.2011.04.009

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  71 in total

1.  Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC.

Authors:  S A Almatroodi; C F McDonald; I A Darby; D S Pouniotis
Journal:  Cancer Microenviron       Date:  2015-08-30

2.  Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics.

Authors:  Jennifer M Speth; Loka R Penke; Joseph D Bazzill; Kyung Soo Park; Rafael Gil de Rubio; Daniel J Schneider; Hideyasu Ouchi; James J Moon; Venkateshwar G Keshamouni; Rachel L Zemans; Vibha N Lama; Douglas A Arenberg; Marc Peters-Golden
Journal:  JCI Insight       Date:  2019-10-17

Review 3.  Immunotherapy for lung cancer: advances and prospects.

Authors:  Li Yang; Liping Wang; Yi Zhang
Journal:  Am J Clin Exp Immunol       Date:  2016-03-23

4.  Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).

Authors:  Chenghai Li; Bin Liu; Zonghan Dai; Yunxia Tao
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

5.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

6.  Chemical transfection of dye-conjugated microRNA precursors for microRNA functional analysis of M2 macrophages.

Authors:  Yee Seng Ng; Hernan Roca; David Fuller; Sudha Sud; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

7.  Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells.

Authors:  Marta Alonso-Nocelo; Theresa M Raimondo; Kyle H Vining; Rafael López-López; Maria de la Fuente; David J Mooney
Journal:  Biofabrication       Date:  2018-03-28       Impact factor: 9.954

Review 8.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

9.  Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer.

Authors:  Kanchan Singh; Melissa A Pruski; Kishore Polireddy; Neal C Jones; Qingzheng Chen; Jun Yao; Wasim A Dar; Florencia McAllister; Cynthia Ju; Holger K Eltzschig; Mamoun Younes; Cesar Moran; Harry Karmouty-Quintana; Haoqiang Ying; Jennifer M Bailey
Journal:  Oncogene       Date:  2019-09-30       Impact factor: 9.867

Review 10.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.